Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer: KEYNOTE-782.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 27, 2023
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane.
Journal: Breast cancer research and treatment
Published: May 09, 2022
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting.
Journal: International journal of molecular sciences
Published: June 16, 2021
Biological effects of AL622, a molecule rationally designed to release an EGFR and a c-Src kinase inhibitor.
Journal: Chemical biology & drug design
Published: September 05, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026